Dermacyte Amniotic Membrane Allograft

Your clinician customized this product information just for you

Dermacyte Amniotic Membrane Allograft, per square centimeter

Dermacyte Matrix is an amniotic membrane allograft.

INTENDED USES: Dermacyte Matrix is used to treat non-infected partial thickness skin ulcers (Diabetic foot Ulcer, Venous Stasis Ulcer, Decubitus Ulcer) greater than 1-month duration and which have not adequately responded to conventional therapy, or as clinically indicated.

CLAIMED BENEFITS: It provides a protective extracellular matrix to cover wounds and support cell attachment and ingrowth during healing of chronic non-healing wounds.

OPTION: Following the preparation of the wound bed to ensure it is free from necrotic tissue, a clinician selects Dermacyte Matrix according to the wound size and applies the product to the wound using aseptic technique followed by compression wraps to secure the product in place.

AM-D10012: Dermacyte, 1 x 2 cm: Q4248

AM-D10022: Dermacyte, 2 x 2 cm: Q4248

AM-D10023: Dermacyte, 2 x 3 cm: Q4248

AM-D10024: Dermacyte, 2 x 4 cm: Q4248

AM-D10044: Dermacyte, 4 x 4 cm: Q4248

AM-D10046: Dermacyte, 4 x 6 cm: Q4248

AM-D10048: Dermacyte, 4 x 8 cm: Q4248

Product Information

The addition of Skin Substitutes or Cellular or Tissue Based Products (CTPs) to certain wounds may afford a healing advantage over dressings and conservative treatments when these options appear insufficient to affect complete healing, after at least a 30 day period of comprehensive conservative therapy. There are currently a wide variety of bioengineered products available for soft tissue coverage to affect closure. • Human skin allografts are derived from donated human skin (cadavers) • Allogeneic matrices are derived from human tissue (fibroblasts or membrane) • Composite matrices are derived from human keratinocytes, fibroblasts and xenogeneic collagen • Acellular matrices are derived from xenogeneic collagen or tissue

Pricing and Suppliers

Is it covered by Medicare Part B?

Medicare covers the application of Cellular and Tissue Based Products (CTPs) for chronic Wounds, which are defined as wounds that do not respond to standard wound treatment for at least a 30 day period during organized comprehensive conservative therapy. Medicare has guidelines that establish what is considered medically necessary and how often an item can be used.

How can I purchase this product?

For Medicare to cover this product, it needs to be ordered and applied by your clinician. A patient cannot purchase it directly from a Durable Medical Equipment (DME) store and receive reimbursement for it.

The table below shows highest and lowest Medicare pricing across the country

Description	Medicare DME co-payment Min / Max
Dermacyte amniotic membrane allograft, per square centimeter	$0.00 / $0.00

Estimated out-of-pocket cost:

If your insurance does not cover this product, you can purchase it directly from any store. A list of online stores and prices is provided below for your convenience. For updated prices, find it on the internet at https://woundreference.com/app/product?id=3703

Other Stores

* Indicates whether store accepts Medicare or commercial insurance, but may not apply to this specific product. See coding, coverage and reimubursement for more information.

The information on this handout is for your convenience and educational purposes only. All product claims and specifications are those of the product suppliers. It does not constitute medical advice or a guarantee for reimbursement. Prices may have changed and suppliers may not have product in stock. Please confirm accuracy and appropriateness of information with insurance carrier and product supplier. Clinician and WoundReference assume no liability for inaccuracies or misstatements about products and insurance coverage.